GenSight Biologics S.A. (EPA: SIGHT)
France
· Delayed Price · Currency is EUR
0.315
-0.004 (-1.10%)
Nov 22, 2024, 5:35 PM CET
GenSight Biologics Employees
GenSight Biologics had 16 employees as of December 31, 2023. The number of employees decreased by 29 or -64.44% compared to the previous year.
Employees
16
Change (1Y)
-29
Growth (1Y)
-64.44%
Revenue / Employee
€179,636
Profits / Employee
€1,827,818
Market Cap
36.28M
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
EssilorLuxottica Société anonyme | 151,292 |
Ipsen S.A. | 5,325 |
Eurofins Scientific SE | 61,798 |
ABIVAX Société Anonyme | 61 |
MedinCell S.A. | 134 |
Eurobio Scientific Société anonyme | 300 |
Inventiva S.A. | 123 |
Nanobiotix S.A. | 102 |
GenSight Biologics News
- 10 days ago - GenSight Biologics Announces Submission of LUMEVOQ® Dossier to ANSM to Prepare for Restart of Early Access Program in France - Business Wire
- 26 days ago - GenSight Biologics Announces Publication of Meta-Analyses Showing Better Outcomes for ND4-LHON Patients Treated with LUMEVOQ® - Business Wire
- 4 weeks ago - GenSight Biologics Reports Cash Position as of September 30, 2024, and Provides Business Update - Business Wire
- 5 weeks ago - GenSight Biologics Announces LUMEVOQ® Scientific Updates at AAO 2024 - Business Wire
- 2 months ago - GenSight Biologics S.A. reports 1H results - Seeking Alpha
- 2 months ago - GenSight Biologics Reports Interim Financial Results for the First Half of 2024, Provides Business Updates - Business Wire
- 4 months ago - GenSight Biologics Reports Cash Position as of June 30, 2024, and Provides Business Update - Business Wire
- 4 months ago - GenSight Biologics Launches Newsletter for Retail Investors - Business Wire